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Objectives: Many patients with Parkinson's disease (PD) suffer from non-motor symptoms like sleep disturbances, excessive daytime
sleepiness and fatigue. The aim of our research was to explore whether fatigue is related to sleepiness and sleep problems, depression and
functional status, controlled for age, gender and disease duration.
Methods: The sample consisted of 78 PD patients from Eastern Slovakia (52% males, mean age 68.8±8.7, mean disease duration 7.2±6.8).
The Multidimensional Fatigue Inventory (5 dimensions), the Epworth Sleepiness Scale, the Pittsburgh Sleep Quality Index, Hospital Anxiety
and Depression Scale and the Unified Parkinson's Disease Rating Scale were used. Demographic data were obtained in a structured
interview. Multiple linear regression was used to analyse the data.
Results: Sleepiness did not show significant association with fatigue in any of the fatigue domains; neither did quality of sleep. Depression
was significantly associated with all domains of fatigue, the strongest being the relationship with general fatigue (β .42), reduced motivation
(β .39), mental fatigue (β .35) (pb .001), and physical fatigue (β .31) (pb .01), while the relationship with reduced activity was less strong
(β .22) (pb .05). Worse functional status was significantly related to reduced activity (β .50), general fatigue (β .35), physical fatigue (β .35),
and mental fatigue (β .35) (pb .001).
Conclusion: Fatigue is not related to daytime sleepiness or night-time sleep dysfunction. Fatigue is more strongly influenced by the presence
of depression and worse functional status.
© 2008 Elsevier B.V. All rights reserved.Keywords: Parkinson's disease; Fatigue; Sleepiness; Quality of sleep1. Introduction
Fatigue is a common symptom in the general population
as well as in people with chronic disorders. Approximately
10% of visits to primary care providers is for assessment of
fatigue [1–5]. In Parkinson's disease (PD) patients the prev-⁎ Corresponding author. Department of Neurology, Medical Faculty,
University of PJ Safarik, Trieda SNP 1, 040 01 Kosice, Slovakia. Tel.: +421
911 128314; fax: +421 55 7898546.
E-mail addresses: eva.havlikova@upjs.sk, e_havlikova@yahoo.com
(E. Havlikova).
0022-510X/$ - see front matter © 2008 Elsevier B.V. All rights reserved.
doi:10.1016/j.jns.2008.02.013alence of fatigue ranges from 33% to 58% [6]. One third of
PD patients consider fatigue their single most disabling
symptom [1,5].
Fatigue is a complex phenomenon involving a number of
psychosocial and behavioural processes. The concept of
fatigue, as a multidimensional phenomenon in Parkinson's
disease patients, was postulated by Lou et al. [7]. It is
characterized by difficulty in initiating and sustaining mental
and physical tasks in the absence of motor or physical
impairment [1,7,8]. The study by Lou et al. demonstrated
that the severity of physical fatigue does not correlate with
108 E. Havlikova et al. / Journal of the Neurological Sciences 270 (2008) 107–113that of mental fatigue, suggesting that the two are to a certain
extent independent [7].
It may be difficult to separate fatigue and sleepiness from
each other. These two terms are often used interchangeably,
or under the general rubric of being ‘tired’, despite the
distinct diagnostic or therapeutic implications that each of
them has [9], leading to suboptimal interventions or
management strategies in response to patients' complaints.
Sleepiness is a ubiquitous phenomenon, experienced not
only as a symptom in a number of medical, psychiatric and
primary sleep disorders, but also as a normal physiological
state by most individuals over any given 24 h period [9].
Sleepiness can be considered abnormal when it occurs at
inappropriate times, or does not occur when desired. Ex-
cessive daytime sleepiness (EDS) was reported in approxi-
mately 15% of PD patients, with an 8-year prevalence of
54% [10]. Its manifestation may be either rapid – ‘sleep
attacks’, or slow – patients may feel sleepy and slowly drift
off to sleep [11]. If unrecognized and untreated, sleepiness
can result in poor attention and memory and even to
accidents. The study by Gjerstad et al. showed that EDS was
related to higher age, male gender and use of dopamine
agonists [10]. Recent studies performed in chronic neurolo-
gical diseases and primary sleep disorders have shown that
the level of fatigue does not correlate with the levels of
daytime sleepiness, suggesting that fatigue and EDS are not
causally related to each other [12,13].
As many as 98% of patients with PD may suffer at some
time from nocturnal symptoms that can disturb their sleep
[11]. These symptoms may be grouped into four broad
categories; insomnia, motor, urinary and neuropsychiatry
problems. PD patients show reduced total sleep time and
sleep efficiency, and an increased number of sleep arousals
and fragmentations of sleep [11]. About 40% of PD patients
take sedatives, significantly more than are taken by elderly
people without PD. Sleep disturbance correlates with disease
severity, and depression is another factor strongly related
with sleep problems [14].
To our knowledge, the relationship between fatigue and
sleep problems has not been studied in a group of PD
patients, and little is known even about patients with other
chronic diseases. The study by Kaynak was performed with
multiple sclerosis (MS) patients [15]; 27 MS patients re-
porting fatigue were compared with 10 MS patients without
fatigue and with 13 participants in the control group.
Fatigued patients were found to have worse sleepiness and
worse quality of their sleep, thus the conclusion was that
fatigue could be partially explained by poor subjective sleep
quality.
Fatigue in PD still remains an imperfectly understood
problem, and it seems to have been recognized as serious
only recently. While more is known about its prevalence and
impact on patients' lives, little progress has been made so far
in understanding its aetiology and pathogenesis. Biological
[16], clinical and psychosocial variables may all play a role
[17,18].A study by Shulman reported fatigue as being associated
with anxiety and activities of daily life, but not with gender,
age or depression, or with motor dysfunction [17]. A study
by Abe et al. also did not find any correlation of fatigue with
motor dysfunction [16]. In a longitudinal study by Alves
et al., fatigue was related to disease severity, depression, and
excessive daytime somnolence (EDS) [18,19].
The aim of our research was to explore whether fatigue is
related to sleepiness and sleep problems, depression and




This cross-sectional study evaluated fatigue in a study
population of 78 patients with Parkinson's disease. The
patients were recruited from the hospitals and outpatients
departments in the East Slovakian region between February
2004 and November 2005. All patients were diagnosed
according to the United Kingdom Parkinson's Disease
Society Brain Clinical Criteria [20] and their mental abilities
were assessed with the Mini-Mental State Examination
(MMSE) [21]. Exclusion criteria were defined as follows: 1.
MMSE lower than 24; 2. disease duration longer than
15 years; 3. presence of co-morbidity associated with the
fatigue variable.
The study was approved by the local Ethics Committee.
Informed consent was obtained from each patient.
2.2. Data collection
Data were collected by means of a mailed questionnaire
comprising questions on socio-demographic background,
medical history and current medication, as well as self-report
questionnaires including the Multidimensional Fatigue
Inventory (MFI), Epworth Sleepiness Scale (ESS), Pitts-
burgh Sleep Quality Index (PSQI) and Hospital Anxiety and
Depression Scale (HADS). After three weeks all patients
were interviewed on relevant issues that were not part of the
questionnaire. After this structured interview, a neurologist
assessed each patient's disease severity with Unified
Parkinson's Disease Rating Scale (UPDRS) Version 3.0
[22], including Hoehn & Yahr staging [23] and the Schwab
and England disability scale [24]. Patients who were not able
to fill in the questionnaires by themselves because of motor
impairment of their hands answered the questions during an
oral interview.
2.3. Measures
Fatigue was assessed with the Multidimensional Fatigue
Inventory (MFI). The MFI is a 20-item self-report instrument
designed and validated by Smets et al. [25]. It measures five
fatigue domains: general fatigue, physical fatigue, mental
Table 2
Description of the study variables in the sample (n=78)













HADS—Anxiety and Depression Scale. ESS—Epworth Sleepiness Scale.
PSQI—Pittsburgh Sleep.
Quality Index. MFI—Multidimensional Fatigue Inventory.
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four items in each domain. The score on each item ranges
from 1 (no fatigue) to 5 (very fatigued), so the score in each
dimension ranges from 4 (no fatigue) to 20 (highest possible
fatigue). This instrument is frequently used for patients with
neurological diseases [7]. The instrument was found to have
good internal consistency with a Cronbach's alpha coeffi-
cient of .89 in our sample. Cronbach's alpha results for the
subscales were as follows: general fatigue .84, physical
fatigue .79, reduced activity .80, reduced motivation .71,
mental fatigue .82.
For the evaluation of daytime somnolence the Epworth
Sleepiness Scale (ESS) [26] was used. ESS relies on
measuring dozing behaviour in eight different situations.
The questionnaire asks the respondent to rate the likelihood
of falling asleep on a scale from 0 to 3, were 0 indicates no
chance and 3 represents the greatest chance of dozing. The
total ESS score is the sum of all the responses and ranges
from 0 to 24, with higher scores reflecting greater sleep
propensity. Consistent with the reports of a number of
previous investigations, a score of 10 as the cut-off point was
used for normal, while scores above this imply pathological
sleepiness [27]. Hagell and Broman demonstrated good
psychometric properties of the ESS in PD patients, giving the
evidence basis for using it in PD [28]. The instrument was
found to have good internal consistency with a Cronbach's
alpha coefficient of .84 in our sample.
The Pittsburgh SleepQuality Index (PSQI) [29]was used to
assess night-time sleeping problems. PSQI assesses global
sleep quality and disturbances in sleep patterns during the
previous month in seven components: subjective sleep quality,
sleep latency, sleep duration, habitual sleep efficiency, sleepTable 1
Demographic and clinical description of the sample (n=78)













7. Antiparkinsonian drugs used
l-dopa 8 (10.3%)
Dopamine agonists 21 (26.8%)
l-dopa+COMT inhibitors 12 (15.4%)
l-dopa+Dopamine agonists 6 (7.7%)
l-dopa+COMT inhibitor+dopamine agonists 6 (7.7%)
Other 25 (32.1%)
UPDRS—Unified Parkinson's Disease Rating Scale. S&E—Schwab &
England Scale. H&Y—Hoehn & Yahr Staging.disturbances, use of sleep medication and daytime dysfunc-
tion. Scoring of answers ranges from 0 (no difficulty) to 3
(severe difficulty). After recoding, each component has
possible scores of 0–3,where 3 indicates the negative extreme.
The global PSQI score is the sum of all the component scores
(range 0–21); a score of 5 or more indicating a poor sleeper.
Although not validated for PD, this instrument is widely used
in PD studies [30–32]. The instrument was found to have good
internal consistency with a Cronbach's alpha coefficient of .81
in our sample.
Depression was assessed using the Hospital Anxiety and
Depression Scale (HADS). This self-administered scale
simultaneously evaluates anxiety (HADS-A) and depres-
sion (HADS-D). It was designed to identify mood disorders
in non-psychiatric outpatients attending hospital consulting
rooms. It consists of 14 items (7 for the assessment of
anxiety and 7 for the assessment of depression) scoring
from 0 (no problem) to 3 (extreme problem). The cut-off
values as proposed by the HADS developers [33] were
applied in order to determine the proportion of patients
considered as unimpaired (not depressed, scoring ≤7 on
each subscale), possibly impaired (8–10 on each subscale),
or probably impaired (≥11 on each subscale). In the pres-
ent study Cronbach's alpha was 0.79 for the depression
domain.
The Unified Parkinson's Disease Rating Scale is a four-
subscale combined scale—mental state, activities of daily
living, motor examination, and complications. Two further
instruments are attached to the UPDRS, namely: (1) a
modified Hoehn & Yahr Staging, an ordinal scale that is
applied to gauge the course of disease over time; and (2) the
Schwab & England Scale, a measure of functional
independence providing scores that, though expressed as
percentages, form an ordinal scale. Scores are obtained by
interview and examination. It is currently used as a standard
reference scale in clinical practice and research [22–24].
Basic socio-demographic data (age, gender) and disease
duration were obtained from the structured interview.
Table 3
Linear regression model: associations of functional status, depression and sleepiness with each of the five domains of MFI (controlled for age, disease duration
and gender)
Step Variables General fatigue Physical fatigue Reduced activity Reduced
motivation
Mental fatigue
beta ΔR2 beta ΔR2 beta ΔR2 beta ΔR2 beta ΔR2
1 Age − .10 .02 − .04 .16 − .03
Gender .02 .14 .01 .02 − .03
Disease duration − .03 .05 − .10 .07 .03 .07 − .07 .10 .04 .07
2 UPDRS .35⁎⁎⁎ .19 .35⁎⁎⁎ .18 .50⁎⁎⁎ .29 .21 .09 .35⁎⁎⁎ .17
3 Depression .43⁎⁎⁎ .16 .31⁎⁎ .09 .22⁎ .04 .39⁎⁎⁎ .13 .35⁎⁎⁎ .10
4 ESS .10 .01 .16 .02 .12 .01 .13 .01 .05 .01
Adjusted R2 .36⁎⁎⁎ .31⁎⁎⁎ .37⁎⁎ .28⁎ .29⁎⁎
UPDRS—Unified Parkinson's Disease Rating Scale, ESS—Epworth Sleepiness Scale; ΔR2—change in explained variance after adding the variable.
⁎ -p≤ .05, ⁎⁎ -p≤ .01, ⁎⁎⁎ -p≤ .001.
110 E. Havlikova et al. / Journal of the Neurological Sciences 270 (2008) 107–1132.4. Statistical analysis
The relationships linking age and gender with disease
duration, functional status, depression and sleepiness or
sleep quality were analyzed with multiple linear regression
analysis, using all separate fatigue domains as dependent
variables. Statistical analyses were performed using the
statistical software program SPSS 12.0 for Windows.
3. Results
Out of 203 patients with PD meeting the inclusion
criteria, 14 did not wish to participate in the study; and 91 did
not respond to the invitation. Total response rate was 38.4%.
Out of those who agreed to participate, 7 patients were
eliminated because of the exclusion criteria, 13 patients were
not included because of missing data (these patients agreed
to participate in the study, filled in the questionnaire, but
refused to come for the oral interview), and 78 remained for
analysis. Non-responders did not differ significantly from the
analyzed group in age (mean difference 1.6 years, SE=1.22;
t=1.315; 95%CI − .798–4.003) or gender (difference be-
tween proportions .095, SE= .066, 95% CI − .0343–0.224)
(difference of proportions test) [34].Table 4
Linear regression model: associations of functional status, depression and sleep qua
and gender)
Step Variables General fatigue Physical fatigue
beta ΔR2 beta ΔR2
1 Age − .09 .05
Gender .01 .12
Disease duration − .02 .05 − .08 .07
2 UPDRS .33⁎⁎ .19 .32⁎⁎ .18
3 Depression .42⁎⁎⁎ .16 .31⁎⁎ .09
4 PSQI .12 .01 .17 .02
Adjusted R2 .36⁎⁎⁎ .31⁎⁎⁎
UPDRS—Unified Parkinson's Disease Rating Scale, PSQI—Pittsburgh Sleep Qu
⁎ -p≤ .05, ⁎⁎ -p≤ .01, ⁎⁎⁎ -p≤ .001.Having completed the questionnaire, the 78 patients were
interviewed, and then subsequently examined by the
neurologist (41 men, 52.6%). The mean age of the patients
was 68.8±8.7 years. Mean age at disease onset was 59.5±
11.1 years. Mean disease duration was 7.2±6.8 years.
Details of the clinical profile and the study variables of the
patients are shown in Tables 1 and 2.
The Spearman's correlation of ESS and PDQI showed no
significant relations (Spearman's coefficient .048).
As sleepiness may be one of the major symptoms re-
flecting sleep disturbances, two models of multiple linear
regression analysis were performed to explore the relative
contributions of functional status, depression and sleepiness
(Table 3), or subjective quality of sleep (Table 4), in each
MFI domain, controlled for age, gender and disease duration.
The Unified Parkinson's Disease Rating Scale had
significant effects on all domains of fatigue except reduced
motivation in both models. Depression had a significant
effect on all fatigue domains in both models, the strongest
being on reduced motivation in both models (beta .50 in the
sleepiness model, and .48 in the quality of sleep model).
Sleepiness did not contribute significantly to fatigue in
any of the fatigue domains (betas ranged from .05 to .16).




beta ΔR2 beta ΔR2 beta ΔR2
− .03 .17 − .02
− .01 .01 − .06
.04 .07 − .05 .10 .05 .07
.48⁎⁎⁎ .29 .20 .10 .31⁎⁎ .17
.21⁎ .05 .40⁎⁎⁎ .13 .32⁎⁎ .10
.16 .02 .09 .01 .20 .04
.38⁎ .28⁎ .32⁎
ality Index, ΔR2—change in explained variance after adding the variable.
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activity and mental fatigue to .02 in physical fatigue and
reduced motivation in the model.
Similar results were found in the quality of sleep model.
Quality of sleep was not a significant variable contributing to
fatigue in any of the fatigue domains (betas ranged from .10
to .20), its R2 change scores ranging from .01 in general
fatigue and reduced motivation, .02 in mental fatigue and
reduced activity to .04 in mental fatigue.
None of the variables which the analysis was controlled
for, whether age or gender or disease duration, proved to be
significant for any of the five fatigue outcomes in either of
the models.
The proposed model for sleepiness explained 36% of the
variance in general fatigue, 31% of the variance in physical
fatigue, 37% in reduced activity, 28% in reduced motivation
and 29% in mental fatigue. The proposedmodel for quality of
sleep explained 36% of the variance in general fatigue, 31%
of the variance in physical fatigue, 38% in reduced activity,
28% in reduced motivation and 32% in mental fatigue.
4. Discussion
The aim of our study was to evaluate whether fatigue is
related to sleepiness and nocturnal sleep problems, depres-
sion and functional status, controlled for age, gender and
disease duration. Neither sleepiness during the day, nor
nocturnal sleep problems (quality of sleep) contributed to
fatigue in any of the five fatigue domains. Depression
contributed significantly to all five fatigue domains, and
functional status to four domains.
Looking closer at fatigue, sleepiness and sleep distur-
bances, clear associations are difficult to define as overlaps
among them exist. Many patients reporting fatigue have
daytime sleepiness or night-time sleep complaints [15], and
many sleep-disordered patients have psychological com-
plaints [13]. The terms are also often used interchangeably,
grouped together by patients under the complaint of being
‘tired’. On closer examination, however, it can be seen that
sleepiness, sleep disturbances and fatigue are distinct, but
interrelated symptoms.
ESS has been described in 8–50% of PD patients [17],
and in our sample it was observed in 25.6% of the patients.
When put into the linear regression model, sleepiness did not
have a significant relationship with fatigue in any of the five
fatigue domains. This contrasts with the study by Alves et al.
[19], who found in a sample of 233 PD patients that fatigue
was associated with excessive daytime sleepiness, although
when the patients with excessive daytime sleepiness were
excluded, the prevalence of fatigue was still high, indicating
the possibility that fatigue may result from sleepiness, but
not necessarily so. The relative independence of fatigue and
sleepiness was also reported for the multiple sclerosis
patients in the study by Kaynak et al. [15], although these
two populations are difficult to compare as MS and PD affect
different age groups.Sleep problems are well-known and well-described non-
motor symptoms in PD. They may result from uncontrolled
motor complications, medication side-effects, or as a result
of degeneration of the neuro-anatomical substrate respon-
sible for the sleep–wake cycle [11]. As many as 60% of PD
patients suffer from sleep disturbances, and up to 98% may
suffer at some time from nocturnal symptoms that can
disturb their sleep [11]. In our sample, 83.3% of patients
reported poor sleep. When analyzing quality of sleep in the
proposed fatigue models, poor sleep quality did not have a
significant relationship to fatigue in any of the five fatigue
domains. Only Karlsen et al., studying a sample of 233 PD
patients, evaluated the association of fatigue and sleep
problems, which they measured in terms of the use of
sedatives; they found that the incidence of fatigue correlated
with the use of sleeping pills [35].
4.1. Mood disorders
Depression is common among PD patients [17]. In our
study it was reported by 14.3% of patients. Depression
proved to be an important contributor to fatigue in all the
fatigue domains; the greater the depression, the greater the
fatigue. These results contrast with those of Shulman et al.
[17], who in their sample of 99 PD patients did not find
fatigue correlating with depression, using the Fatigue
Severity Scale and the Beck Depression Inventory. Similar
results to Shulman were published by Abe in a sample of 26
PD patients [16], using the Fatigue Severity Scale and
Zung's self-assessed depression scale. Looking at the
multidimensional construct of fatigue, Lou et al. with a
sample of 39 PD patients found that depression was
associated with the mental dimension of fatigue, but not
with the physical dimensions [7]. The relationship between
fatigue and depression is still controversial as there may be
an overlap between them; fatigue is among the diagnostic
criteria for depression.
4.2. Functional status
We found that functional status had a significant influence
on fatigue for the domains of general fatigue, physical
fatigue and mental fatigue, the strongest being with the
domain of reduced activity. These findings do not corre-
spond with previous results. In their study of 233 PD
patients, Karlsen et al. [35] found that disease severity did
not have significant associations with fatigue, measured with
the Nottingham health profile questionnaire, in its dimension
“lack of energy”; and Lou et al. [7] also found no significant
correlations of disease severity measured with Hoehn & Yahr
with any of the dimensions in the MFI.
4.3. Limitations
Our sample consisted mostly of patients who were able
to come for the interview, so we assume that the non-
112 E. Havlikova et al. / Journal of the Neurological Sciences 270 (2008) 107–113responders were patients with worse functional status
compared to those in our sample. Nonetheless, our study
suggests that even in this selected population of PD patients,
fatigue is already a serious problem.
As fatigue was shown to be a complex construct, with the
physical and mental components independent from each other
[7], the Multidimensional Fatigue Inventory was selected for
measuring fatigue. This instrument as a generic measure also
gives the possibility of comparisons with other diseases, in
contrast to the disease-specific Parkinson's Fatigue Scale [36],
or the Fatigue Severity Scale, which measures fatigue per
se [37].
4.4. Implications
In our study we discovered that all the fatigue domains,
mental as well as physical, are strongly related to depression
and worse functional status, but are independent from
subjective sleep disorders or sleepiness. As symptoms of
fatigue and sleep dysfunction overlap, further research should
be performed, cross-sectional as well as longitudinal, to better
understand these associations. The explanation of this issue is
important as it may influence the future clinical management
of PD patients. We also stress the importance of identifying
possible treatable disorders leading to fatigue. Recognition
and proper treatment of depression, and proper management
of the disease symptoms, may lead to improvement in both
the mental and the physical dimensions of fatigue.
5. Conclusions
Fatigue is not related to daytime sleepiness or night-time
sleep dysfunction. Fatigue is more strongly influenced by the
presence of depression and worse functional status.
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